Symbol: DIVISLAB
Month: 2024-12
Start Price: ₹6255.35
End Price: ₹6098.80
12M Return: -2.50%
6M Return: -2.50%
3M Return: -2.50%
Volatility: 0.203
Sharpe Ratio: -1.473
Max Drawdown: -0.076
Peer Correlation (DRREDDY): -0.2131
Peer Correlation (SUNPHARMA): 0.1343
Peer Correlation (CIPLA): 0.047
Average Peer Correlation: -0.0106

Generate a short summary and suggest whether to BUY, SELL, or HOLD.

--- LLM Output ---
**Summary:**

Divi's Laboratories (DIVISLAB) has underperformed in the last 12 months, with a return of -2.50%. The stock's volatility is moderate at 0.203, and its Sharpe Ratio is -1.473, indicating that the return is not justified by the risk taken. The maximum drawdown is -0.076, which is relatively low. The peer correlation analysis shows that DIVISLAB has a negative correlation with DRREDDY, a positive correlation with SUNPHARMA, and a near-zero correlation with CIPLA. The average peer correlation is -0.0106, suggesting that DIVISLAB's performance is not closely tied to its peers.

**Recommendation:**

Based on the analysis, I would recommend a **HOLD** on DIVISLAB. The stock's underperformance in the last 12 months, combined with its negative Sharpe Ratio, suggests that it may not be an attractive investment opportunity at this time. However, the moderate volatility and low maximum drawdown indicate that the stock may not be extremely risky. Additionally, the peer correlation analysis suggests that DIVISLAB's performance is not closely tied to its peers, which may indicate that it has the potential to perform differently in the future. Therefore, a HOLD recommendation is warranted, pending further analysis and monitoring of the stock's performance.